Obstructive sleep apnea and coronary artery disease

Sleep Medicine Reviews

Volumn 12, Issue 1, 2008, Pages 19-31

  Lüthje, Lars ^a   Andreas, Stefan ^b  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b Fachklinik fur Lungenerkrankungen   (Germany)

Author keywords

Continuous positive airway pressure; Coronary artery disease; Sleep apnea; Sudden cardiac death; Sympathetic activity

Indexed keywords

CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; HEART DEATH; HEART VENTRICLE ARRHYTHMIA; HUMAN; HYPERTENSION; MORBIDITY; MORTALITY; PATHOPHYSIOLOGY; POSITIVE END EXPIRATORY PRESSURE; PROGNOSIS; REVIEW; SLEEP APNEA SYNDROME; ST SEGMENT; SUDDEN DEATH; SYMPATHETIC NERVE;

CAUSE OF DEATH; CONTINUOUS POSITIVE AIRWAY PRESSURE; CORONARY ARTERY DISEASE; DEATH, SUDDEN, CARDIAC; HUMANS; HYPERTENSION; MYOCARDIAL ISCHEMIA; SLEEP APNEA, OBSTRUCTIVE; SYMPATHETIC NERVOUS SYSTEM; TACHYCARDIA, VENTRICULAR;

EID: 38049026709     PISSN: 10870792     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.smrv.2007.08.002     Document Type: Review

References (172)

1. Meyer J., Breithardt G., Erbel R., Erdmann E., Gohlke H., Hanrath P., et al. Leitlinie Koronare Herzkrankheit/Angina pectoris. Z Kardiol 87 (1998) 907-911
2. Willich S., Löwel H., Mey W., and Trautner C. Regionale Unterschiede der Herz-Kreislauf-Mortalität. Deut Ärzteblatt 96 (1999) 378-383
3. Final report on the aspirin component of the ongoing Physicians' Health Study. Steering Committee of the Physicians' Health Study Research Group. N Engl J Med 321 3 (1989) 129-135
4. Young T., Palta M., Dempsey J., Skatrud J., Weber S., and Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 328 17 (1993) 1230-1235
5. Phillipson E.A. Sleep apnea-a major public health problem. N Engl J Med 328 17 (1993) 1271-1273
6. Arias M.A., Garcia-Rio F., Alonso-Fernandez A., Mediano O., Martinez I., and Villamor J. Obstructive sleep apnea syndrome affects left ventricular diastolic function: effects of nasal continuous positive airway pressure in men. Circulation 112 3 (2005) 375-383
7. Bradley T.D., and Floras J.S. Sleep apnea and heart failure: Part I: obstructive sleep apnea. Circulation 107 12 (2003) 1671-1678
8. Yaggi H.K., Concato J., Kernan W.N., Lichtman J.H., Brass L.M., and Mohsenin V. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 353 19 (2005) 2034-2041
9. Gami A.S., Pressman G., Caples S.M., Kanagala R., Gard J.J., Davison D.E., et al. Association of atrial fibrillation and obstructive sleep apnea. Circulation 110 4 (2004) 364-367
10. Schulz R., Eisele H.J., Weissmann N., and Seeger W. Pulmonary hypertension and sleep-related breathing disorders. Pneumologie 59 4 (2005) 270-274
11. Shiomi T., Guilleminault C., Stoohs R., and Schnittger I. Leftward shift of the interventricular septum and pulsus paradoxus in obstructive sleep apnea syndrome. Chest 100 4 (1991) 894-902
12. Shamsuzzaman A.S., Gersh B.J., and Somers V.K. Obstructive sleep apnea: implications for cardiac and vascular disease. JAMA 290 14 (2003) 1906-1914
13. Brinker J.A., Weiss J.L., Lappe D.L., Rabson J.L., Summer W.R., Permutt S., et al. Leftward septal displacement during right ventricular loading in man. Circulation 61 3 (1980) 626-633
14. Virolainen J., Ventila M., Turto H., and Kupari M. Effect of negative intrathoracic pressure on left ventricular pressure dynamics and relaxation. J Appl Physiol 79 2 (1995) 455-460
15. Bradley T.D., Hall M.J., Ando S., and Floras J.S. Hemodynamic effects of simulated obstructive apneas in humans with and without heart failure. Chest 119 6 (2001) 1827-1835
16. Parker J.D., Brooks D., Kozar L.F., Render-Teixeira C.L., Horner R.L., Douglas Bradley T., et al. Acute and chronic effects of airway obstruction on canine left ventricular performance. Am J Respir Crit Care Med 160 6 (1999) 1888-1896
17. Bradley T.D. Right and left ventricular functional impairment and sleep apnea. Clin Chest Med 13 3 (1992) 459-479
18. Tolle F.A., Judy W.V., Yu P.L., and Markand O.N. Reduced stroke volume related to pleural pressure in obstructive sleep apnea. J Appl Physiol 55 6 (1983) 1718-1724
19. Narkiewicz K., and Somers V.K. Sympathetic nerve activity in obstructive sleep apnoea. Acta Physiol Scand 177 3 (2003) 385-390
20. Somers V.K., Mark A.L., Zavala D.C., and Abboud F.M. Contrasting effects of hypoxia and hypercapnia on ventilation and sympathetic activity in humans. J Appl Physiol 67 5 (1989) 2101-2106
21. Morgan B.J., Denahan T., and Ebert T.J. Neurocirculatory consequences of negative intrathoracic pressure vs. asphyxia during voluntary apnea. J Appl Physiol 74 6 (1993) 2969-2975
22. Narkiewicz K., van de Borne P.J., Montano N., Dyken M.E., Phillips B.G., and Somers V.K. Contribution of tonic chemoreflex activation to sympathetic activity and blood pressure in patients with obstructive sleep apnea. Circulation 97 10 (1998) 943-945
23. Narkiewicz K., van de Borne P.J., Pesek C.A., Dyken M.E., Montano N., and Somers V.K. Selective potentiation of peripheral chemoreflex sensitivity in obstructive sleep apnea. Circulation 99 9 (1999) 1183-1189
24. Horner R.L., Brooks D., Kozar L.F., Tse S., and Phillipson E.A. Immediate effects of arousal from sleep on cardiac autonomic outflow in the absence of breathing in dogs. J Appl Physiol 79 1 (1995) 151-162
25. Somers V.K., Dyken M.E., Mark A.L., and Abboud F.M. Sympathetic-nerve activity during sleep in normal subjects. N Engl J Med 328 5 (1993) 303-307
26. Narkiewicz K., Montano N., Cogliati C., van de Borne P.J., Dyken M.E., and Somers V.K. Altered cardiovascular variability in obstructive sleep apnea. Circulation 98 11 (1998) 1071-1077
27. Somers V.K., Dyken M.E., Clary M.P., and Abboud F.M. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 96 4 (1995) 1897-1904
28. Narkiewicz K., van de Borne P.J., Cooley R.L., Dyken M.E., and Somers V.K. Sympathetic activity in obese subjects with and without obstructive sleep apnea. Circulation 98 8 (1998) 772-776
29. **The most important references are denoted by an asterisk. Carlson J.T., Hedner J., Elam M., Ejnell H., Sellgren J., and Wallin B.G. Augmented resting sympathetic activity in awake patients with obstructive sleep apnea. Chest 103 6 (1993) 1763-1768
30. Fletcher E.C. Sympathetic over activity in the etiology of hypertension of obstructive sleep apnea. Sleep 26 1 (2003) 15-19
31. Phillips B.G., and Somers V.K. Neural and humoral mechanisms mediating cardiovascular responses to obstructive sleep apnea. Respir Physiol 119 2-3 (2000) 181-187
32. Caples S.M., Gami A.S., and Somers V.K. Obstructive sleep apnea. Ann Intern Med 142 3 (2005) 187-197
33. Curtis B.M., and O'Keefe Jr. J.H. Autonomic tone as a cardiovascular risk factor: the dangers of chronic fight or flight. Mayo Clin Proc 77 1 (2002) 45-54
34. Brook R.D., and Julius S. Autonomic imbalance, hypertension, and cardiovascular risk. Am J Hypertens 13 6 Part 2 (2000) 112S-122S
35. Andreas S., Anker S.D., Scanlon P.D., and Somers V.K. Neurohumoral activation as a link to systemic manifestations of chronic lung disease. Chest 128 5 (2005) 3618-3624
36. Lattimore J.L., Wilcox I., Skilton M., Langenfeld M., and Celermajer D.S. Treatment of obstructive sleep apnoea leads to improved microvascular endothelial function in the systemic circulation. Thorax 61 6 (2006) 491-495
37. Anker S.D., and Coats A.J. Cardiac cachexia: a syndrome with impaired survival and immune and neuroendocrine activation. Chest 115 3 (1999) 836-847
38. Packer M. The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. J Am Coll Cardiol 20 1 (1992) 248-254
39. Ip M.S., Lam B., Ng M.M., Lam W.K., Tsang K.W., and Lam K.S. Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 165 5 (2002) 670-676
40. Phillips B.G., Kato M., Narkiewicz K., Choe I., and Somers V.K. Increases in leptin levels, sympathetic drive, and weight gain in obstructive sleep apnea. Am J Physiol Heart Circ Physiol 279 1 (2000) H234-H237
41. Schulz R. The vascular micromilieu in obstructive sleep apnoea. Eur Respir J 25 5 (2005) 780-782
42. Elmasry A., Lindberg E., Berne C., Janson C., Gislason T., Awad Tageldin M., et al. Sleep-disordered breathing and glucose metabolism in hypertensive men: a population-based study. J Intern Med 249 2 (2001) 153-161
43. Viot-Blanc V., and Levy P. Sleep apnea and glucose metabolism: the new challenge. Sleep Med 7 7 (2006) 538-540
44. Davi G., Guagnano M.T., Ciabattoni G., Basili S., Falco A., Marinopiccoli M., et al. Platelet activation in obese women: role of inflammation and oxidant stress. JAMA 288 16 (2002) 2008-2014
45. Coughlin S.R., Mawdsley L., Mugarza J.A., Calverley P.M., and Wilding J.P. Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J 25 9 (2004) 735-741
46. Gami A.S., and Somers V.K. Obstructive sleep apnoea, metabolic syndrome, and cardiovascular outcomes. Eur Heart J 25 9 (2004) 709-711
47. Lavie C.J., and Milani R.V. Obesity and cardiovascular disease: the hippocrates paradox?. J Am Coll Cardiol 42 4 (2003) 677-679
48. Allison D.B., Fontaine K.R., Manson J.E., Stevens J., and VanItallie T.B. Annual deaths attributable to obesity in the United States. JAMA 282 16 (1999) 1530-1538
49. MacMahon S.W., Wilcken D.E., and Macdonald G.J. The effect of weight reduction on left ventricular mass. A randomized controlled trial in young, overweight hypertensive patients. N Engl J Med 314 6 (1986) 334-339
50. *. Schulz R., Schmidt D., Blum A., Lopes-Ribeiro X., Lucke C., Mayer K., et al. Decreased plasma levels of nitric oxide derivatives in obstructive sleep apnoea: response to CPAP therapy. Thorax 55 12 (2000) 1046-1051
51. Phillips B.G., Narkiewicz K., Pesek C.A., Haynes W.G., Dyken M.E., and Somers V.K. Effects of obstructive sleep apnea on endothelin-1 and blood pressure. J Hypertens 17 1 (1999) 61-66
52. Nieto F.J., Herrington D.M., Redline S., Benjamin E.J., and Robbins J.A. Sleep apnea and markers of vascular endothelial function in a large community sample of older adults. Am J Respir Crit Care Med 169 3 (2004) 354-360
53. Ip M.S., Tse H.F., Lam B., Tsang K.W., and Lam W.K. Endothelial function in obstructive sleep apnea and response to treatment. Am J Respir Crit Care Med 169 3 (2004) 348-353
54. Schulz R., Grebe M., Eisele H.J., Mayer K., Weissmann N., and Seeger W. Obstructive sleep apnea-related cardiovascular disease. Med Klin (Munich) 101 4 (2006) 321-327
55. Schulz R., Olschewski H., Grimminger F., and Seeger W. Obstructive sleep apnea and cardiovascular diseases-hypothesis on the pathophysiological interlinks. Pneumologie 55 6 (2001) 295-301
56. Grebe M., Eisele H.J., Weissmann N., Schaefer C., Tillmanns H., Seeger W., et al. Antioxidant vitamin C improves endothelial function in obstructive sleep apnea. Am J Respir Crit Care Med 173 8 (2006) 897-901
57. Bonetti P.O., Lerman L.O., and Lerman A. Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol 23 2 (2003) 168-175
58. Vita J.A., and Keaney Jr. J.F. Endothelial function: a barometer for cardiovascular risk?. Circulation 106 6 (2002) 640-642
59. Duchna H G.L., Andreas S., Schulz R., Wessendorf T., Becker H., et al. Sleep-disordered breathing and cardio- and cerebrovascular diseases: 2003 update of clinical significance and future perspectives. Somnology 7 (2003) 101-121
60. Schulz R., Mahmoudi S., Hattar K., Sibelius U., Olschewski H., Mayer K., et al. Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy. Am J Respir Crit Care Med 162 2 Part 1 (2000) 566-570
61. Halliwell B. The role of oxygen radicals in human disease, with particular reference to the vascular system. Haemostasis 23 Suppl. 1 (1993) 118-126
62. Dean R.T., and Wilcox I. Possible atherogenic effects of hypoxia during obstructive sleep apnea. Sleep 16 8 Suppl. (1993) S15-S21 [discussion S21-2]
63. Dyugovskaya L., Lavie P., and Lavie L. Phenotypic and functional characterization of blood gammadelta T cells in sleep apnea. Am J Respir Crit Care Med 168 2 (2003) 242-249
64. Barcelo A., Barbe F., de la Pena M., Vila M., Perez G., Pierola J., et al. Antioxidant status in patients with sleep apnoea and impact of continuous positive airway pressure treatment. Eur Respir J 27 4 (2006) 756-760
65. Ridker P.M., Buring J.E., Cook N.R., and Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation 107 3 (2003) 391-397
66. Danesh J., Whincup P., Walker M., Lennon L., Thomson A., Appleby P., et al. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ 321 7255 (2000) 199-204
67. Vgontzas A.N., Papanicolaou D.A., Bixler E.O., Kales A., Tyson K., and Chrousos G.P. Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. J Clin Endocrinol Metab 82 5 (1997) 1313-1316
68. Tazaki T., Minoguchi K., Yokoe T., Samson K.T., Minoguchi H., Tanaka A., et al. Increased levels and activity of matrix metalloproteinase-9 in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 170 12 (2004) 1354-1359
69. Svatikova A., Wolk R., Shamsuzzaman A.S., Kara T., Olson E.J., and Somers V.K. Serum amyloid a in obstructive sleep apnea. Circulation 108 12 (2003) 1451-1454
70. Shamsuzzaman A.S., Winnicki M., Lanfranchi P., Wolk R., Kara T., Accurso V., et al. Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation 105 21 (2002) 2462-2464
71. Chin K., Nakamura T., Shimizu K., Mishima M., Miyasaka M., and Ohi M. Effects of nasal continuous positive airway pressure on soluble cell adhesion molecules in patients with obstructive sleep apnea syndrome. Am J Med 109 7 (2000) 562-567
72. Dyugovskaya L., Lavie P., Hirsh M., and Lavie L. Activated CD8+ T-lymphocytes in obstructive sleep apnoea. Eur Respir J 25 5 (2005) 820-828
73. Lentini S., Manka R., Scholtyssek S., Stoffel-Wagner B., Luderitz B., and Tasci S. Creatine phosphokinase elevation in obstructive sleep apnea syndrome: an unknown association?. Chest 129 1 (2006) 88-94
74. Silvestrini M., Rizzato B., Placidi F., Baruffaldi R., Bianconi A., and Diomedi M. Carotid artery wall thickness in patients with obstructive sleep apnea syndrome. Stroke 33 7 (2002) 1782-1785
75. Drager L.F., Bortolotto L.A., Lorenzi M.C., Figueiredo A.C., Krieger E.M., and Lorenzi-Filho G. Early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med 172 5 (2005) 613-618
76. Bassetti C.L. Obstructive sleep apnea and atherosclerosis: "guilt by association". Am J Respir Crit Care Med 172 5 (2005) 518-519
77. Schulz R., Seeger W., Fegbeutel C., Husken H., Bodeker R.H., Tillmanns H., et al. Changes in extracranial arteries in obstructive sleep apnoea. Eur Respir J 25 1 (2005) 69-74
78. Minoguchi K., Yokoe T., Tazaki T., Minoguchi H., Tanaka A., Oda N., et al. Increased carotid intima-media thickness and serum inflammatory markers in obstructive sleep apnea. Am J Respir Crit Care Med 172 5 (2005) 625-630
79. Chin K., Ohi M., Kita H., Noguchi T., Otsuka N., Tsuboi T., et al. Effects of NCPAP therapy on fibrinogen levels in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 153 6 Part 1 (1996) 1972-1976
80. Hoffstein V., Herridge M., Mateika S., Redline S., and Strohl K.P. Hematocrit levels in sleep apnea. Chest 106 3 (1994) 787-791
81. Nobili L., Schiavi G., Bozano E., De Carli F., Ferrillo F., and Nobili F. Morning increase of whole blood viscosity in obstructive sleep apnea syndrome. Clin Hemorheol Microcirc 22 1 (2000) 21-27
82. Wessendorf T.E., Thilmann A.F., Wang Y.M., Schreiber A., Konietzko N., and Teschler H. Fibrinogen levels and obstructive sleep apnea in ischemic stroke. Am J Respir Crit Care Med 162 6 (2000) 2039-2042
83. Hanly P., Sasson Z., Zuberi N., and Lunn K. ST-segment depression during sleep in obstructive sleep apnea. Am J Cardiol 71 15 (1993) 1341-1345
84. Alonso-Fernandez A., Garcia-Rio F., Racionero M.A., Pino J.M., Ortuno F., Martinez I., et al. Cardiac rhythm disturbances and ST-segment depression episodes in patients with obstructive sleep apnea-hypopnea syndrome and its mechanisms. Chest 127 1 (2005) 15-22
85. Andreas S., Hajak G., Natt P., Auge D., Ruther E., and Kreuzer H. ST segmental changes and arrhythmias in obstructive sleep apnea. Pneumologie 45 9 (1991) 720-724
86. Franklin K.A., Nilsson J.B., Sahlin C., and Naslund U. Sleep apnoea and nocturnal angina. Lancet 345 8957 (1995) 1085-1087
87. Schafer H., Koehler U., Ploch T., and Peter J.H. Sleep-related myocardial ischemia and sleep structure in patients with obstructive sleep apnea and coronary heart disease. Chest 111 2 (1997) 387-393
88. *. Mooe T., Franklin K.A., Wiklund U., Rabben T., and Holmstrom K. Sleep-disordered breathing and myocardial ischemia in patients with coronary artery disease. Chest 117 6 (2000) 1597-1602
89. Junker-Neff A., Eberle R., v Arnim T., Mehilli J., and Hollweck R. Is there an association between the sleep apnea syndrome and the circadian peak of myocardial infarction in the morning hours?. Dtsch Med Wochenschr 130 49 (2005) 2818-2822
90. Aboyans V., Cassat C., Lacroix P., Tapie P., Tabaraud F., Pesteil F., et al. Is the morning peak of acute myocardial infarction's onset due to sleep-related breathing disorders? A prospective study. Cardiology 94 3 (2000) 188-192
91. Koehler U., Trautmann M., Trautmann R., Tabarelli O., Cassel W., Heitmann J., et al. Does sleep apnea increase the risk of myocardial infarct during sleep?. Z Kardiol 88 6 (1999) 410-417
92. Nakashima H., Katayama T., Takagi C., Amenomori K., Ishizaki M., Honda Y., et al. Obstructive sleep apnoea inhibits the recovery of left ventricular function in patients with acute myocardial infarction. Eur Heart J 27 19 (2006) 2317-2322
93. Shepard Jr. J.W., Garrison M.W., Grither D.A., and Dolan G.F. Relationship of ventricular ectopy to oxyhemoglobin desaturation in patients with obstructive sleep apnea. Chest 88 3 (1985) 335-340
94. Guilleminault C., Connolly S.J., and Winkle R.A. Cardiac arrhythmia and conduction disturbances during sleep in 400 patients with sleep apnea syndrome. Am J Cardiol 52 5 (1983) 490-494
95. Flemons W.W., Remmers J.E., and Gillis A.M. Sleep apnea and cardiac arrhythmias. Is there a relationship?. Am Rev Respir Dis 148 3 (1993) 618-621
96. Fichter J., Bauer D., Arampatzis S., Fries R., Heisel A., and Sybrecht G.W. Sleep-related breathing disorders are associated with ventricular arrhythmias in patients with an implantable cardioverter-defibrillator. Chest 122 2 (2002) 558-561
97. Harbison J., O'Reilly P., and McNicholas W.T. Cardiac rhythm disturbances in the obstructive sleep apnea syndrome: effects of nasal continuous positive airway pressure therapy. Chest 118 3 (2000) 591-595
98. Mehra R., Benjamin E.J., Shahar E., Gottlieb D.J., Nawabit R., Kirchner H.L., et al. Association of nocturnal arrhythmias with sleep-disordered breathing: The Sleep Heart Health Study. Am J Respir Crit Care Med 173 8 (2006) 910-916
99. Roche F., Gaspoz J.M., Court-Fortune I., Costes F., Geyssant A., Duverney D., et al. Alteration of QT rate dependence reflects cardiac autonomic imbalance in patients with obstructive sleep apnea syndrome. Pacing Clin Electrophysiol 26 7 Part 1 (2003) 1446-1453
100. *. Gami A.S., Howard D.E., Olson E.J., and Somers V.K. Day-night pattern of sudden death in obstructive sleep apnea. N Engl J Med 352 12 (2005) 1206-1214
101. Willich S.N., Klatt S., and Arntz H.R. Circadian variation and triggers of acute coronary syndromes. Eur Heart J 19 Suppl. C (1998) C12-C23
102. Leor J., Poole W.K., and Kloner R.A. Sudden cardiac death triggered by an earthquake. N Engl J Med 334 7 (1996) 413-419
103. Schulz R., Eisele H., Weissmann N., and Seeger W. Obstructive sleep apnea-an important cardiovascular risk factor. Deut Ärzteblatt 103 (2006) A775-A781
104. Logan A.G., Perlikowski S.M., Mente A., Tisler A., Tkacova R., Niroumand M., et al. High prevalence of unrecognized sleep apnoea in drug-resistant hypertension. J Hypertens 19 12 (2001) 2271-2277
105. Brooks D., Horner R.L., Kozar L.F., Render-Teixeira C.L., and Phillipson E.A. Obstructive sleep apnea as a cause of systemic hypertension. Evidence from a canine model. J Clin Invest 99 1 (1997) 106-109
106. Fletcher E.C., and Bao G. The rat as a model of chronic recurrent episodic hypoxia and effect upon systemic blood pressure. Sleep 19 10 Suppl. (1996) S210-S212
107. Hamilton G.S., Solin P., and Naughton M.T. Obstructive sleep apnoea and cardiovascular disease. Intern Med J 34 7 (2004) 420-426
108. Carlson J.T., Hedner J.A., Ejnell H., and Peterson L.E. High prevalence of hypertension in sleep apnea patients independent of obesity. Am J Respir Crit Care Med 150 1 (1994) 72-77
109. Worsnop C.J., Naughton M.T., Barter C.E., Morgan T.O., Anderson A.I., and Pierce R.J. The prevalence of obstructive sleep apnea in hypertensives. Am J Respir Crit Care Med 157 1 (1998) 111-115
110. Nieto F.J., Young T.B., Lind B.K., Shahar E., Samet J.M., Redline S., et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA 283 14 (2000) 1829-1836
111. *. Peppard P.E., Young T., Palta M., and Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 342 19 (2000) 1378-1384
112. Bixler E.O., Vgontzas A.N., Lin H.M., Ten Have T., Leiby B.E., Vela-Bueno A., et al. Association of hypertension and sleep-disordered breathing. Arch Intern Med 160 15 (2000) 2289-2295
113. Hedner J., Bengtsson-Bostrom K., Peker Y., Grote L., Rastam L., and Lindblad U. Hypertension prevalence in obstructive sleep apnoea and sex: a population-based case-control study. Eur Respir J 27 3 (2006) 564-570
114. Chobanian A.V., Bakris G.L., Black H.R., Cushman W.C., Green L.A., Izzo Jr. J.L., et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 289 19 (2003) 2560-2572
115. Sampol G., Romero O., Salas A., Tovar J.L., Lloberes P., Sagales T., et al. Obstructive sleep apnea and thoracic aorta dissection. Am J Respir Crit Care Med 168 12 (2003) 1528-1531
116. Mooe T., Rabben T., Wiklund U., Franklin K.A., and Eriksson P. Sleep-disordered breathing in men with coronary artery disease. Chest 109 3 (1996) 659-663
117. De Olazabal J.R., Miller M.J., Cook W.R., and Mithoefer J.C. Disordered breathing and hypoxia during sleep in coronary artery disease. Chest 82 5 (1982) 548-552
118. Sebel J., and Kolenda D. Prävalenz der obstruktiven Schlafapnoe bei Patienten mit koronarer Herzerkrankung. Herz Kreis 27 (1995) 153-158
119. Andreas S., Schulz R., Werner G.S., and Kreuzer H. Prevalence of obstructive sleep apnoea in patients with coronary artery disease. Coron Artery Dis 7 7 (1996) 541-545
120. Peker Y., Kraiczi H., Hedner J., Loth S., Johansson A., and Bende M. An independent association between obstructive sleep apnoea and coronary artery disease. Eur Respir J 14 1 (1999) 179-184
121. Koehler U., and Schafer H. An independent association between obstructive sleep apnoea and coronary artery disease. Is obstructive sleep apnea (OSA) a risk factor for myocardial infarction and cardiac arrhythmias in patients with coronary heart disease (CHD)?. Sleep 19 4 (1996) 283-286
122. Schafer H., Koehler U., Ewig S., Hasper E., Tasci S., and Luderitz B. Obstructive sleep apnea as a risk marker in coronary artery disease. Cardiology 92 2 (1999) 79-84
123. Hung J., Whitford E.G., Parsons R.W., and Hillman D.R. Association of sleep apnoea with myocardial infarction in men. Lancet 336 8710 (1990) 261-264
124. Sanner B., Sturm A., and Konermann M. Coronary heart disease in patients with obstructive sleep apnea. Dtsch Med Wochenschr 121 30 (1996) 931-935
125. Young T., Shahar E., Nieto F.J., Redline S., Newman A.B., Gottlieb D.J., et al. Predictors of sleep-disordered breathing in community-dwelling adults: the Sleep Heart Health Study. Arch Intern Med 162 8 (2002) 893-900
126. Franklin K.A., Gislason T., Omenaas E., Jogi R., Jensen E.J., Lindberg E., et al. The influence of active and passive smoking on habitual snoring. Am J Respir Crit Care Med 170 7 (2004) 799-803
127. Peker Y., Hedner J., Kraiczi H., and Loth S. Respiratory disturbance index: an independent predictor of mortality in coronary artery disease. Am J Respir Crit Care Med 162 1 (2000) 81-86
128. *. Peker Y., Hedner J., Norum J., Kraiczi H., and Carlson J. Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea: a 7-year follow-up. Am J Respir Crit Care Med 166 2 (2002) 159-165
129. Peker Y., Carlson J., and Hedner J. Increased incidence of coronary artery disease in sleep apnoea: a long-term follow-up. Eur Respir J 28 3 (2006) 596-602
130. Mooe T., Franklin K.A., Holmstrom K., Rabben T., and Wiklund U. Sleep-disordered breathing and coronary artery disease: long-term prognosis. Am J Respir Crit Care Med 164 10 Part 1 (2001) 1910-1913
131. *. Marin J.M., Carrizo S.J., Vicente E., and Agusti A.G. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 365 9464 (2005) 1046-1053
132. Smith P.L., Gold A.R., Meyers D.A., Haponik E.F., and Bleecker E.R. Weight loss in mildly to moderately obese patients with obstructive sleep apnea. Ann Intern Med 103 6 (Part 1) (1985) 850-855
133. Ferguson K.A., Cartwright R., Rogers R., and Schmidt-Nowara W. Oral appliances for snoring and obstructive sleep apnea: a review. Sleep 29 2 (2006) 244-262
134. Pepin J.L., Veale D., Mayer P., Bettega G., Wuyam B., and Levy P. Critical analysis of the results of surgery in the treatment of snoring, upper airway resistance syndrome (UARS), and obstructive sleep apnea (OSA). Sleep 19 9 Suppl. (1996) S90-S100
135. Garrigue S., Bordier P., Jais P., Shah D.C., Hocini M., Raherison C., et al. Benefit of atrial pacing in sleep apnea syndrome. N Engl J Med 346 6 (2002) 404-412
136. Luthje L., Unterberg-Buchwald C., Dajani D., Vollmann D., Hasenfuss G., and Andreas S. Atrial overdrive pacing in patients with sleep apnea with implanted pacemaker. Am J Respir Crit Care Med 172 1 (2005) 118-122
137. Unterberg C., Luthje L., Szych J., Vollmann D., Hasenfuss G., and Andreas S. Atrial overdrive pacing compared to CPAP in patients with obstructive sleep apnoea syndrome. Eur Heart J 26 23 (2005) 2568-2575
138. Simantirakis E.N., Schiza S.E., Chrysostomakis S.I., Chlouverakis G.I., Klapsinos N.C., Siafakas N.M., et al. Atrial overdrive pacing for the obstructive sleep apnea-hypopnea syndrome. N Engl J Med 353 24 (2005) 2568-2577
139. Sullivan C.E., Issa F.G., Berthon-Jones M., and Eves L. Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares. Lancet 1 8225 (1981) 862-865
140. Engleman H.M., Martin S.E., Deary I.J., and Douglas N.J. Effect of continuous positive airway pressure treatment on daytime function in sleep apnoea/hypopnoea syndrome. Lancet 343 8897 (1994) 572-575
141. Sforza E., Capecchi V., and Lugaresi E. Haemodynamic effects of short-term nasal continuous positive airway pressure therapy in sleep apnoea syndrome: monitoring by a finger arterial pressure device. Eur Respir J 5 7 (1992) 858-863
142. Bonsignore M.R., Parati G., Insalaco G., Castiglioni P., Marrone O., Romano S., et al. Baroreflex control of heart rate during sleep in severe obstructive sleep apnoea: effects of acute CPAP. Eur Respir J 27 1 (2006) 128-135
143. Ali N.J., Davies R.J., Fleetham J.A., and Stradling J.R. The acute effects of continuous positive airway pressure and oxygen administration on blood pressure during obstructive sleep apnea. Chest 101 6 (1992) 1526-1532
144. Tkacova R., Rankin F., Fitzgerald F.S., Floras J.S., and Bradley T.D. Effects of continuous positive airway pressure on obstructive sleep apnea and left ventricular afterload in patients with heart failure. Circulation 98 21 (1998) 2269-2275
145. Naughton M.T., Rahman M.A., Hara K., Floras J.S., and Bradley T.D. Effect of continuous positive airway pressure on intrathoracic and left ventricular transmural pressures in patients with congestive heart failure. Circulation 91 6 (1995) 1725-1731
146. *. Narkiewicz K., Kato M., Phillips B.G., Pesek C.A., Davison D.E., and Somers V.K. Nocturnal continuous positive airway pressure decreases daytime sympathetic traffic in obstructive sleep apnea. Circulation 100 23 (1999) 2332-2335
147. Usui K., Bradley T.D., Spaak J., Ryan C.M., Kubo T., Kaneko Y., et al. Inhibition of awake sympathetic nerve activity of heart failure patients with obstructive sleep apnea by nocturnal continuous positive airway pressure. J Am Coll Cardiol 45 12 (2005) 2008-2011
148. Waradekar N.V., Sinoway L.I., Zwillich C.W., and Leuenberger U.A. Influence of treatment on muscle sympathetic nerve activity in sleep apnea. Am J Respir Crit Care Med 153 4 Part 1 (1996) 1333-1338
149. Ziegler M.G., Mills P.J., Loredo J.S., Ancoli-Israel S., and Dimsdale J.E. Effect of continuous positive airway pressure and placebo treatment on sympathetic nervous activity in patients with obstructive sleep apnea. Chest 120 3 (2001) 887-893
150. Ip M.S., Lam B., Chan L.Y., Zheng L., Tsang K.W., Fung P.C., et al. Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure. Am J Respir Crit Care Med 162 6 (2000) 2166-2171
151. Shimizu K., Chin K., Nakamura T., Masuzaki H., Ogawa Y., Hosokawa R., et al. Plasma leptin levels and cardiac sympathetic function in patients with obstructive sleep apnoea-hypopnoea syndrome. Thorax 57 5 (2002) 429-434
152. Chin K., Shimizu K., Nakamura T., Narai N., Masuzaki H., Ogawa Y., et al. Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy. Circulation 100 7 (1999) 706-712
153. Czupryniak L., Loba J., Pawlowski M., Nowak D., and Bialasiewicz P. Treatment with continuous positive airway pressure may affect blood glucose levels in nondiabetic patients with obstructive sleep apnea syndrome. Sleep 28 5 (2005) 601-603
154. Punjabi N.M., Ahmed M.M., Polotsky V.Y., Beamer B.A., and O'Donnell C.P. Sleep-disordered breathing, glucose intolerance, and insulin resistance. Respir Physiol Neurobiol 136 2-3 (2003) 167-178
155. Smurra M., Philip P., Taillard J., Guilleminault C., Bioulac B., and Gin H. CPAP treatment does not affect glucose-insulin metabolism in sleep apneic patients. Sleep Med 2 3 (2001) 207-213
156. Bokinsky G., Miller M., Ault K., Husband P., and Mitchell J. Spontaneous platelet activation and aggregation during obstructive sleep apnea and its response to therapy with nasal continuous positive airway pressure. A preliminary investigation. Chest 108 3 (1995) 625-630
157. Sanner B.M., Konermann M., Tepel M., Groetz J., Mummenhoff C., and Zidek W. Platelet function in patients with obstructive sleep apnoea syndrome. Eur Respir J 16 4 (2000) 648-652
158. Peled N., Abinader E.G., Pillar G., Sharif D., and Lavie P. Nocturnal ischemic events in patients with obstructive sleep apnea syndrome and ischemic heart disease: effects of continuous positive air pressure treatment. J Am Coll Cardiol 34 6 (1999) 1744-1749
159. Roche F., Barthelemy J.C., Garet M., Duverney D., Pichot V., and Sforza E. Continuous positive airway pressure treatment improves the QT rate dependence adaptation of obstructive sleep apnea patients. Pacing Clin Electrophysiol 28 8 (2005) 819-825
160. Javaheri S. Effects of continuous positive airway pressure on sleep apnea and ventricular irritability in patients with heart failure. Circulation 101 4 (2000) 392-397
161. Ryan C.M., Usui K., Floras J.S., and Bradley T.D. Effect of continuous positive airway pressure on ventricular ectopy in heart failure patients with obstructive sleep apnoea. Thorax 60 9 (2005) 781-785
162. Faccenda J.F., Mackay T.W., Boon N.A., and Douglas N.J. Randomized placebo-controlled trial of continuous positive airway pressure on blood pressure in the sleep apnea-hypopnea syndrome. Am J Respir Crit Care Med 163 2 (2001) 344-348
163. Pepperell J.C., Ramdassingh-Dow S., Crosthwaite N., Mullins R., Jenkinson C., Stradling J.R., et al. Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. Lancet 359 9302 (2002) 204-210
164. *. Becker H.F., Jerrentrup A., Ploch T., Grote L., Penzel T., Sullivan C.E., et al. Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 107 1 (2003) 68-73
165. Hui D.S., To K.W., Ko F.W., Fok J.P., Chan M.C., Ngai J.C., et al. Nasal CPAP reduces systemic blood pressure in patients with obstructive sleep apnoea and mild sleepiness. Thorax 61 12 (2006) 1083-1090
166. Norman D., Loredo J.S., Nelesen R.A., Ancoli-Israel S., Mills P.J., Ziegler M.G., et al. Effects of continuous positive airway pressure versus supplemental oxygen on 24-hour ambulatory blood pressure. Hypertension 47 5 (2006) 840-845
167. Barnes M., Houston D., Worsnop C.J., Neill A.M., Mykytyn I.J., Kay A., et al. A randomized controlled trial of continuous positive airway pressure in mild obstructive sleep apnea. Am J Respir Crit Care Med 165 6 (2002) 773-780
168. Campos-Rodriguez F., Grilo-Reina A., Perez-Ronchel J., Merino-Sanchez M., Gonzalez-Benitez M.A., Beltran-Robles M., et al. Effect of continuous positive airway pressure on ambulatory BP in patients with sleep apnea and hypertension: a placebo-controlled trial. Chest 129 6 (2006) 1459-1467
169. Barbe F., Mayoralas L.R., Duran J., Masa J.F., Maimo A., Montserrat J.M., et al. Treatment with continuous positive airway pressure is not effective in patients with sleep apnea but no daytime sleepiness. A randomized, controlled trial. Ann Intern Med 134 11 (2001) 1015-1023
170. Robinson G.V., Smith D.M., Langford B.A., Davies R.J., and Stradling J.R. Continuous positive airway pressure does not reduce blood pressure in nonsleepy hypertensive OSA patients. Eur Respir J 27 6 (2006) 1229-1235
171. *. Milleron O., Pilliere R., Foucher A., de Roquefeuil F., Aegerter P., Jondeau G., et al. Benefits of obstructive sleep apnoea treatment in coronary artery disease: a long-term follow-up study. Eur Heart J 25 9 (2004) 728-734
172. Doherty L.S., Kiely J.L., Swan V., and McNicholas W.T. Long-term effects of nasal continuous positive airway pressure therapy on cardiovascular outcomes in sleep apnea syndrome. Chest 127 6 (2005) 2076-2084